Showing 1981-1990 of 2736 results for "".
- Sciton Launches diVa® Center of Excellence Programhttps://modernaesthetics.com/news/sciton-launches-diva-center-of-excellence-program/2472230/Sciton, Inc.’s new diVa® Center of Excellence Program will spotlight urogynecologists, urologists, OB/GYN's and gynecologists who are dedicated to creating an optimal Treatment Experience for women. The Centers will review data and outcome
- NJ Plastic Surgeon Dr. Barry Dibernardo To Lead ASERFhttps://modernaesthetics.com/news/nj-plastic-surgeon-barry-dibernardo-md-to-lead-aserf/2472233/New Jersey-based plastic surgeon Barry Dibernardo, MD is the new President of the Aesthetic Surgery Education And Research Foundation. ASERF is the philanthropic research and education arm of the American Society fo
- Plastic Surgeons Offer Video Tips To Maximize Safety During Filler Injectionshttps://modernaesthetics.com/news/plastic-surgeons-offer-tips-to-maximize-safety-during-filler-injections/2472236/Avoiding key "danger zones" may help plastic surgeons enhance the safety and effectiveness of facial filler procedures, according to an expert update in the May issue of Plastic and Reconstructive Surgery®. The article out
- Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studieshttps://modernaesthetics.com/news/restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit-in-phase-4-studies/2472251/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na
- Deadline Extended for Medical Spa State of the Industry Statistical Studyhttps://modernaesthetics.com/news/deadline-extended-for-medical-spa-state-of-the-industry-statistical-study/2472272/The American Med Spa Association (AmSpa) has extended the deadline for the 2017 Medical Spa St
- Review Charts Anatomically Driven Advances in East Asian Rhinoplastyhttps://modernaesthetics.com/news/review-charts-anatomically-driven-advances-in-east-asian-rhinoplasty/2486869/A recent review published online in Journal of Craniofacial Surgery examines the evolution of nasal tip rhinoplasty in East Asia, highlighting a transition from imported Western techniques to regionally tailored innovations grounded in anatomic and cultural considerations. Nasal t
- AAD 2026: Revance to Showcase Expanding Aesthetics Portfoliohttps://modernaesthetics.com/news/aad-2026-revance-to-showcase-expanding-aesthetics-portfolio/2486383/Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Dual Biologic Therapy Promotes Hair Follicle Regeneration in Preclinical Studyhttps://modernaesthetics.com/news/dual-biologic-therapy-promotes-hair-follicle-regeneration-in-preclinical-study/2485066/New preclinical research suggests that combining botulinum neurotoxin type A (BoNT/A) with platelet-rich plasma (PRP) may synergistically promote hair follicle regeneration through activation of the Wnt/β-catenin signaling pathway and modulation of stathmin 1 (STMN1) protein expression. The findi